140 related articles for article (PubMed ID: 9037411)
41. Effects of diet and time of the day on serum and CSF leptin levels in Osborne-Mendel and S5B/Pl rats.
Ishihara Y; White CL; Kageyama H; Kageyama A; York DA; Bray GA
Obes Res; 2004 Jul; 12(7):1067-76. PubMed ID: 15292470
[TBL] [Abstract][Full Text] [Related]
42. Enterostatin--a peptide regulating fat intake.
Erlanson-Albertsson C; York D
Obes Res; 1997 Jul; 5(4):360-72. PubMed ID: 9285845
[TBL] [Abstract][Full Text] [Related]
43. Enterostatin (APGPR) enhances memory consolidation in mice.
Ohinata K; Sonoda S; Shimano T; Yoshikawa M
Peptides; 2007 Mar; 28(3):719-21. PubMed ID: 17175068
[TBL] [Abstract][Full Text] [Related]
44. Peptides that regulate food intake: separable mechanisms for dorsal hindbrain CART peptide to inhibit gastric emptying and food intake.
Smedh U; Moran TH
Am J Physiol Regul Integr Comp Physiol; 2003 Jun; 284(6):R1418-26. PubMed ID: 12468444
[TBL] [Abstract][Full Text] [Related]
45. Plasma enterostatin: identification and release in rats in response to a meal.
Mei J; Sörhede-Winzell M; Erlanson-Albertsson C
Obes Res; 2002 Jul; 10(7):688-94. PubMed ID: 12105292
[TBL] [Abstract][Full Text] [Related]
46. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses food intake and gastric emptying with the elevation of plasma peptide YY and glucagon-like peptide-1 in a dietary fat-dependent manner.
Hata T; Mera Y; Ishii Y; Tadaki H; Tomimoto D; Kuroki Y; Kawai T; Ohta T; Kakutani M
J Pharmacol Exp Ther; 2011 Mar; 336(3):850-6. PubMed ID: 21139060
[TBL] [Abstract][Full Text] [Related]
47. Lack of interaction between peripheral injection of CCK and obestatin in the regulation of gastric satiety signaling in rodents.
Gourcerol G; Million M; Adelson DW; Wang Y; Wang L; Rivier J; St-Pierre DH; Taché Y
Peptides; 2006 Nov; 27(11):2811-9. PubMed ID: 16934368
[TBL] [Abstract][Full Text] [Related]
48. Intravenous enterostatin does not affect single meal food intake in man.
Rössner S; Barkeling B; Erlanson-Albertsson C; Larsson P; Wåhlin-Boll E
Appetite; 1995 Feb; 24(1):37-42. PubMed ID: 7741534
[TBL] [Abstract][Full Text] [Related]
49. Effect of a selective OX1R antagonist on food intake and body weight in two strains of rats that differ in susceptibility to dietary-induced obesity.
White CL; Ishii Y; Mendoza T; Upton N; Stasi LP; Bray GA; York DA
Peptides; 2005 Nov; 26(11):2331-8. PubMed ID: 15893404
[TBL] [Abstract][Full Text] [Related]
50. Pancreatic procolipase propeptide, enterostatin, specifically inhibits fat intake.
Erlanson-Albertsson C; Mei J; Okada S; York D; Bray GA
Physiol Behav; 1991 Jun; 49(6):1191-4. PubMed ID: 1896501
[TBL] [Abstract][Full Text] [Related]
51. Ghrelin attenuates the inhibitory effects of glucagon-like peptide-1 and peptide YY(3-36) on food intake and gastric emptying in rats.
Chelikani PK; Haver AC; Reidelberger RD
Diabetes; 2006 Nov; 55(11):3038-46. PubMed ID: 17065340
[TBL] [Abstract][Full Text] [Related]
52. The role of enterostatin and apolipoprotein AIV on the control of food intake.
Liu M; Shen L; Tso P
Neuropeptides; 1999 Oct; 33(5):425-33. PubMed ID: 10657520
[TBL] [Abstract][Full Text] [Related]
53. CNS injection of CCK in rats: effects on real and sham feeding and gastric emptying.
Della-Fera MA; Coleman BD; Baile CA
Am J Physiol; 1990 May; 258(5 Pt 2):R1165-9. PubMed ID: 2337197
[TBL] [Abstract][Full Text] [Related]
54. Adrenalectomy of the obese Zucker rat: effects on the feeding response to enterostatin and specific mRNA levels.
Okada S; Onai T; Kilroy G; York DA; Bray GA
Am J Physiol; 1993 Jul; 265(1 Pt 2):R21-7. PubMed ID: 8393627
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of gastric emptying by peripheral and central fenfluramine in rats: correlation with anorexia.
Rowland N; Carlton J
Life Sci; 1984 Jun; 34(25):2495-9. PubMed ID: 6727578
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of insulin release by intraduodenally infused enterostatin-VPDPR in rats.
Mei J; Bouras M; Erlanson-Albertsson C
Peptides; 1997; 18(5):651-5. PubMed ID: 9213357
[TBL] [Abstract][Full Text] [Related]
57. Proglumide, a cholecystokinin antagonist, increases gastric emptying in rats.
Shillabeer G; Davison JS
Am J Physiol; 1987 Feb; 252(2 Pt 2):R353-60. PubMed ID: 3812772
[TBL] [Abstract][Full Text] [Related]
58. Intracerebroventricular administration of MK-801 increases food intake through mechanisms independent of gastric emptying.
Covasa M; Hung CY; Ritter RC; Burns GA
Am J Physiol Regul Integr Comp Physiol; 2004 Dec; 287(6):R1462-7. PubMed ID: 15358605
[TBL] [Abstract][Full Text] [Related]
59. Endogenous cholecystokinin does not decrease food intake or gastric emptying in fasted rats.
Smith GP; Greenberg D; Falasco JD; Avilion AA; Gibbs J; Liddle RA; Williams JA
Am J Physiol; 1989 Dec; 257(6 Pt 2):R1462-6. PubMed ID: 2604005
[TBL] [Abstract][Full Text] [Related]
60. Effect of high-fat diet, surrounding temperature, and enterostatin on uncoupling protein gene expression.
Rippe C; Berger K; Böiers C; Ricquier D; Erlanson-Albertsson C
Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E293-300. PubMed ID: 10913028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
